Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity.
Hiraoka K, Inagaki A, Kato Y, Huang TT, Mitchell LA, Kamijima S, Takahashi M, Matsumoto H, Hacke K, Kruse CA, Ostertag D, Robbins JM, Gruber HE, Jolly DJ, Kasahara N.
Hiraoka K, et al. Among authors: hacke k.
Neuro Oncol. 2017 Jul 1;19(7):918-929. doi: 10.1093/neuonc/nox038.
Neuro Oncol. 2017.
PMID: 28387831
Free PMC article.